Search

Plant phenology describes the timing of reproductive events including flowering and fruiting, which for many species are affected by fire disturbance. Understanding phenological responses to fire provides insights into how forest demographics and resources may shift alongside increasing fire frequency and intensity driven by climate change. However, isolating the direct effects of fire on a species' phenology and excluding potential confounders (e.g. climate, soil) has been difficult due to the logistical challenges of monitoring species-specific phenological events across myriad fire and environmental conditions. Here, we use CubeSat-derived crown-scale flowering data to estimate the effects of fire history (time since fire and fire severity over a 15-year time span) on flowering of the eucalypt Corymbia calophylla across a Mediterranean-climate forest (814km 2 ) in southwest Australia. We found that fire reduced the proportion of flowering trees at the landscape-scale, and flowering recovered at a rate of 0.15 % (±0.11% SE) per year. Further, this negative effect was significant due to high crown scorch fires (>20% canopy scorch), yet there was no significant effect from understory burns. Estimates were obtained using a quasi-experimental design which identifies the effect of time since fire and severity on flowering by comparing proportional flowering within target fire perimeters (treatment) and adjacent past fire perimeters (control). Given the majority of fires studied were managed fuel reduction burns, we applied the estimates to hypothetical fire regimes to compare flowering outcomes under more or less frequent prescribed burning. This research demonstrates the landscape-scale effects of burning on a tree species' reproduction, which could broadly impact forest resiliency and biodiversity., Competing Interests: Declaration of competing interest The work described here has not been published previously. It is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)

The bromodomain family of proteins are 'readers' of acetylated lysines of histones, a key mark in the epigenetic code of gene regulation. Without high quality chemical probes with which to study these proteins, their biological function, and potential use in therapeutics, remains unknown. Recently, a number of chemical ligands were reported for the previously unprobed bromodomain proteins BRD7 and BRD9. Herein the development and characterisation of probes against these proteins is detailed, including the preliminary biological activity of BRD7 and BRD9 assessed using these probes. Future studies utilising these chemically-diverse compounds in parallel will allow for a confident assessment of the role of BRD7/9, and give multiple entry points into any subsequent pharmaceutical programs., (Copyright © 2016 Elsevier Ltd. All rights reserved.)

Clinicians performing psychiatric assessments of potential organ donors must consider the motivations behind an act that is--strictly in terms of its physiological implications--entirely altruistic. The authors present two case reports in which proposed kidney donors conceptualized their offers exclusively in terms of their religious beliefs and not in terms of kinship or emotional intimacy with the intended recipients. The negative reactions of some clinicians to the offers reveal the readiness with which religious beliefs can be pathologized and the way in which biological relationships can unduly restrict the clinical understanding of healthy altruism.

Transfusion-induced hemosiderosis is a serious and potentially life-threatening complication for some patients with sickle cell anemia. The use of high-dose intravenous deferoxamine (DFO) has become widespread in spite of a paucity of published data on safety and efficacy. We report a randomized double-blind study of the dose-response relationship of intravenous DFO in six subjects with sickle cell anemia and severe transfusion-induced hemosiderosis (serum ferritin 4100 to 14,176 ng/ml). Each subject received three different doses of intravenous DFO for 3 days each while consuming a constant diet. Total iron excretion (urine and fecal) was 91% greater at 180 mg/kg/day DFO than at 60 mg/kg/day DFO, and fecal iron excretion became a relatively larger proportion of total excretion at higher doses. Subsequent treatment for 3 months with 150 mg/kg/day DFO caused a 33% to 60% reduction in serum ferritin and demonstrable improvement in hepatic function in all patients. No toxicity was encountered, but DFO at 180 mg/kg/day was associated with a significant increase in fecal zinc excretion when compared with that observed at lower doses.